Work

Onasemnogene Abeparvovec: First Global Approval

Year: 2019

Type: review

Source: Drugs

DOI: 10.1007/s40265-019-01162-5

Author: Sheridan M. Hoy

Institution: Springer Nature (New Zealand)

Language: English

Topic: Neurogenetic and Muscular Disorders Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955699452

FWCI: 7.578

Cites: 19

Cited by: 337

Related to: 10